By William A. Haseltine This story is part of a larger mosaic of stories on Post-Acute Sequelae of Covid-19 (PASC), also known as Long Covid. Read part one and two of this series. Comparing brain volume before and after individuals were exposed to...
A group of researchers at the University Medical Center Mannheim affiliated with prominent German academic medical centers, including Heidelberg University, have analyzed COVID-19 breakthrough vaccines since July 13, 2021, as part of an extended...
Pfizer CEO Albert Bourla made news last week when he went on the CBS news program Face the Nation and advocated for a fourth covid vaccine booster shot and a subsequent annual shot. Shortly after, Moderna came out and also pushed for emergency approval of a...
— Cognitive tests show "notable reduction" in memory ability by Judy George Seven in 10 people, most of whom said they had long COVID, experienced concentration and memory problems months after acute SARS-CoV-2 infection and many performed worse than their peers on...
Beijing is fine-tuning its virus response playbook to try to limit the cost of restrictions. But its goal of eliminating all infections could make that difficult. By Amy Qin and Amy Chang Chien When the coronavirus first swept across China in early 2020, the country’s...
Deltacron is an emerging new variant. Are there specific symptoms? By Herb Scribner Scientists said that they have identified a new hybrid version of the coronavirus called “deltacron” — which combines the delta and the omicron variants of the virus. Driving...
Not only one of the most vaccinated peoples in the world, but the population of South Korea are also one of the most boosted. Yet SARS-CoV-2, the virus behind COVID-19, rages at record levels leading to record deaths. U.S. health authorities have advised...
Pfizer recently announced that the large American pharmaceutical company along with German partner BioNTech SE (BNTX) has applied to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for an additional booster dose targeted for adults...
The Wall Street Journal’s Allysia Finley, member of the prominent business paper’s editorial board has gone out on the proverbial limb and aligned with Florida’s Surgeon General Joseph Ladapo who announced on March 7 that in the Sunshine State children wouldn’t need...
In a seemingly quick reversal after contradicting Pfizer’s request for a fourth shot, Moderna has suddenly asked the Food and Drug Administration (FDA) to approve an emergency request for an additional booster shot of their vaccine. Moderna said...
By PIEN HUANG Even as this winter's omicron surge recedes, more than 2,000 people in the U.S. still get hospitalized with COVID-19 each day. This population is largely unvaccinated, with medical conditions that increase their risks. Some of these...
A study linked SARS-CoV-2 infections with smaller brain regions, but the implications are unclear By Laura Sanders Like all writers, I spend large chunks of my time looking for words. When it comes to the ultracomplicated and mysterious brain, I need words that...
A fourth COVID-19 vaccine fails to offer appropriate protection, reports a Sheba Medical Center-based study in Israel published in the New England Journal of Medicine. This means that a fourth mRNA-based dose may only introduce marginal benefits to young, healthy...
Similar bills are working their way through the legislature in Oklahoma, Missouri, Indiana, Arizona, and Alaska. By Sophie Mann New Hampshire's GOP-led House has passed a bill that would allow pharmacists to dispense Ivermectin under a standard order, meaning...
All epidemics trigger the same Sisyphean cycle of panic and neglect. Even so, that cycle isn’t meant to spin this quickly. By Ed Yong All epidemics trigger the same dispiriting cycle. First, panic: As new pathogens emerge, governments throw money, resources, and...